Stay updated on ADG116 Combination Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combination Immunotherapy Clinical Trial page.

Latest updates to the ADG116 Combination Immunotherapy Clinical Trial page
- ChecktodayChange DetectedStudy status updated to Completed on 2026-01-08; the previous Active, not recruiting status was removed on 2024-08-14. This indicates the trial has moved from recruitment to completion.SummaryDifference0.7%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new Revision: v3.3.3 entry was added to the history, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedThe Record History now includes a new revision entry v3.3.2 and removes the previous revision v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedThe Record History now lists Revision v3.3.1 and removes Revision v3.2.0 from the study record history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe government funding/operating status notice was removed from the page. The page content related to the study remains unchanged.SummaryDifference0.8%

- Check72 days agoChange DetectedVersion history shows updates to recruitment status and study design, along with changes to eligibility criteria and references. The latest version (2024-08-13) updates the study status and related location details.SummaryDifference0.1%

Stay in the know with updates to ADG116 Combination Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combination Immunotherapy Clinical Trial page.